Carl Zeiss Ownership
| CZMWF Stock | USD 61.22 0.00 0.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Carl |
Carl Pink Sheet Ownership Analysis
About 59.0% of the company shares are held by company insiders. The company last dividend was issued on the 23rd of March 2023. Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3531 people.The quote for Carl Zeiss Meditec is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Carl Zeiss Meditec please contact Markus Weber at 49 3641 220 115 or go to https://www.zeiss.de/meditec-ag/home.html.Currently Active Assets on Macroaxis
Other Information on Investing in Carl Pink Sheet
Carl Zeiss financial ratios help investors to determine whether Carl Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carl with respect to the benefits of owning Carl Zeiss security.